Neuropathic pain is a debilitating condition affecting millions of people worldwide. A new study investigates mechanisms of neuropathic pain initiation and identifies a promising therapeutic currently used for acute respiratory distress syndrome that may also limit acute neuropathic pain.
References
International Association for the Study of Pain. Epidemiology of neuropathic pain: how common is neuropathic pain, and what is its impact? (IASP, 2015).
Baron, R., Binder, A. & Wasner, G. Lancet Neurol. 9, 807–819 (2010).
Finnerup, N.B. et al. Lancet 14, 162–173 (2015).
Cohen, S.P. & Mao, J. Br. Med. J. 348, f7656 (2014).
Vicuña, L. et al. Nat. Med. 21, 518–523 (2015).
Aikawa, N. & Kawasaki, Y. Ther. Clin. Risk Manag. 10, 621–629 (2014).
Zeiher, B.G. et al. Crit. Care Med. 32, 1695–1702 (2004).
Finnerup, N.B. et al. Eur. J. Pain 17, 953–956 (2013).
Berufsverband der Ärtze und Psychologischen Psychotherapeutan in der Schmerz- und Palliativmedizin in Deutschland (BVSD). Weißbuch Schmerzmedizin [White Book on Pain Medicine] (BVSD, 2012).
Von Hehn, C.A., Baron, R. & Woolf, C.J. Neuron 73, 638–652 (2012).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Weyer, A., Stucky, C. Repurposing a leukocyte elastase inhibitor for neuropathic pain. Nat Med 21, 429–430 (2015). https://doi.org/10.1038/nm.3861
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.3861
- Springer Nature America, Inc.